Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters

Publication year range
1.
Am J Emerg Med ; 37(10): 1993.e1-1993.e3, 2019 10.
Article in English | MEDLINE | ID: mdl-31262624

ABSTRACT

Pneumatosis intestinalis (PI) refers to the presence of gas within the wall of the small or large intestine. PI can be both asymptomatic and life-threatening. The patient was a 50-year-old man with previous cervical spine abscess and osteomyelitis post debridement 4 years ago, with a heroin abuse history. He presented with abdominal distension ongoing for 4 days and vomiting for 3 times with fluid content. Abdominal computed tomography revealed pneumatosis with pneumoretroperitoneum. A surgeon was contacted and antibiotic treatment was started. The patient was kept on nothing per os and intravenous fluid supply. A drainage tube was inserted into retroperitoneum space on the same day. Tracing back his history, our patient was discharged from the hospital recently with a diagnosis of superior mesenteric artery dyndrome (SMAS), hypersensitivity pneumonitis, and asbestosis with soft tissue pleural plaques and calcified pleural plaques. During the hospitalization period, hydrocortisone dexamethasone and methylprednisolone were prescribed for hypersensitivity pneumonitis. Steroid use and SMAS maybe the cause of PI. Finally, he was discharged 5 days later with a nasojejunal and drainage tubes and was arranged for OPD follow-up. PI can be asymptomatic or life-threatening, and patient management varies based on the clinical condition. Although in this case PI was found in the emergency department, a patient's past history of underlying disease and medication should be reviewed to find the most possible etiology.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Hydrocortisone/therapeutic use , Methylprednisolone/therapeutic use , Pneumatosis Cystoides Intestinalis/diagnostic imaging , Pneumoperitoneum/diagnostic imaging , Superior Mesenteric Artery Syndrome/diagnostic imaging , Heroin Dependence/complications , Humans , Male , Medical History Taking , Middle Aged , Pneumatosis Cystoides Intestinalis/drug therapy , Pneumatosis Cystoides Intestinalis/pathology , Pneumoperitoneum/drug therapy , Pneumoperitoneum/pathology , Radiography, Abdominal , Superior Mesenteric Artery Syndrome/drug therapy , Superior Mesenteric Artery Syndrome/pathology , Treatment Outcome , Vomiting
2.
BMC Anesthesiol ; 15: 129, 2015 Sep 28.
Article in English | MEDLINE | ID: mdl-26415531

ABSTRACT

BACKGROUND: Pneumoperitoneum-induced oxidative stress and organ injury are known to be associated with nitric oxide (NO) inactivation. Because arginase competes with NO synthase (NOS) for a common substrate, L-arginine, arginase inhibition may increase NO bioavailability. Therefore, we evaluated the ability of the arginase inhibitor, 2 (S)-amino-6-boronohexanoic acid (ABH), to attenuate pneumoperitoneum-induced decrease of NO bioavailability and lung injury. METHODS: Thirty rats were randomly divided into the following groups: 1) the PP-ABH group received a subcutaneous injection of ABH (5 mg/kg) 1 h before induction of pneumoperitoneum (insufflation to intraperitoneal pressure of 15 mmHg for 60 min); 2) the PP group received saline by subcutaneous injection 1 h before induction of pneumoperitoneum; and 3) the control group received saline by subcutaneous injection before a sham procedure with no gas insufflation. After desufflation, blood was collected to determine levels of plasma nitrite, NOS, inflammatory cytokines, and malondialdehyde, a marker of oxidative stress. Lung tissue was obtained for histological evaluation. RESULTS: We found that plasma nitrite levels were lower in the PP group and higher in the PP-ABH group, compared with controls (P <0.01 and P <0.05, respectively). In the PP group, endothelial NOS activity was decreased and inducible NOS activity was increased compared with the PP-ABH and control groups. Malondialdehyde levels increased 3-fold in the PP group and 2-fold in the PP-ABH group compared with controls. Tumor necrosis factor-α, interleukin-6, and interleukin-1ß levels were elevated in the PP group compared to the control group, but the increase in cytokine production was attenuated or blocked in the PP-ABH group. Lung injury scores were 4.8-fold higher in the PP group and 2-fold higher in the PP-ABH group compared with controls (P <0.001 and P <0.01, respectively). DISCUSSION: Pneumoperitoneum decreases NO bioavailability and increases the inflammation cytokines, resulting in organ injuries. Inhibition of arginase activity could maintain NO bioavailability by attenuating pneumoperitoneum-induced changes in NOS activity. In addition, arginase inhibition attenuated the oxidative stress and inflammation and decreased the severity of lung injury caused by pneumoperitoneum. CONCLUSIONS: By increasing NO bioavailability and suppressing oxidative stress and inflammation, pretreatment with an arginase inhibitor may protect against lung injury caused by pneumoperitoneum.


Subject(s)
Aminocaproates/pharmacology , Arginase/antagonists & inhibitors , Boron Compounds/pharmacology , Inflammation/prevention & control , Oxidative Stress/drug effects , Pneumoperitoneum/complications , Aminocaproates/administration & dosage , Animals , Boron Compounds/administration & dosage , Cytokines/metabolism , Disease Models, Animal , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacology , Inflammation/etiology , Injections, Subcutaneous , Lung Injury/etiology , Lung Injury/prevention & control , Male , Malondialdehyde/metabolism , Nitric Oxide/metabolism , Pneumoperitoneum/drug therapy , Rats , Rats, Sprague-Dawley
3.
Clin Invest Med ; 37(3): E124, 2014 Jun 01.
Article in English | MEDLINE | ID: mdl-24895987

ABSTRACT

PURPOSE: The duration of pneumoperitoneum during laparoscopic procedures may contribute to post-surgical oxidative stress. Previous studies have shown that low-dose ketamine, an anesthetic with anti-inflammatory properties, protects various organs from ischemia-reperfusion injury. This study investigated the effects of low-dose ketamine on the overproduction of oxidants and the tissue damage caused by intra-abdominal pressure during CO2 pneumoperitoneum. METHODS: Male Sprague Dawley rats received a CO2 pneumoperitoneum of 15 mmHg and preceded by either low-dose ketamine (KP1, 5 mg/kg; KP2, 10 mg/kg) or 0.9% saline (PR, 3 ml). General anethesia was provided by pentobarbital and sevoflurane. The control group (CR) received an intraperitoneal saline injection and sham surgery. Three hours after pneumoperitoneum, serum concentrations of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), malondialdehyde (MDA), superoxide dismutase (SOD) and intestinal fatty acid binding protein (iFABP) were measured and liver, kidney, lung, and intestine were evaluated for tissue damage. RESULTS: The highest plasma MDA, TNF-α, IL-6 and iFABP values were observed at T1 (after 3 hours of pneumoperitoneum) in the PR group, followed by the KP1, KP2, and CR groups (P < 0.01). SOD concentrations showed an opposite trend and were highest in the CR group, followed by the KP2, KP1, and PR groups (P < 0.01). TNF-α concentration was significantly lower in the KP2 than the KP1 group (P < 0.05). Histopathologic scoring of organ sections demonstrated the lowest scores in the KP2 group, followed by the KP1 and PR groups, in an increasing order (P < 0.05). CONCLUSION: Pretreatment with low-dose ketamine before general anaesthesia protects against potential oxidative damage and inflammatory response caused by CO2 pneumoperitoneum.


Subject(s)
Carbon Dioxide/adverse effects , Ketamine/therapeutic use , Oxidative Stress/drug effects , Pneumoperitoneum/drug therapy , Animals , Interleukin-6/metabolism , Male , Malondialdehyde/metabolism , Rats , Rats, Sprague-Dawley , Reperfusion Injury/prevention & control , Tumor Necrosis Factor-alpha/metabolism
4.
Asian J Anesthesiol ; 61(2): 71-80, 2023 06 01.
Article in English | MEDLINE | ID: mdl-37553724

ABSTRACT

BACKGROUND: Dexmedetomidine is a potent α_2 agonist which has been used for blunting the stress responses during critical events such as laryngoscopy, endotracheal intubation, pneumoperitoneum creation, and extubation. The purpose of this study was to see the efficacy of intravenously administered dexmedetomidine at a dose of 0.5 mcg/kg in attenuating the hemodynamic responses due to pneumoperitoneum during laparoscopic cholecystectomy under general anesthesia. METHODS: Sixty patients, ASA-PS class I (American Society of Anesthesiologist physical status class I), aged between 18 and 60 years, of either sex with weight ranging from 50 to 80 kg, scheduled for laparoscopic cholecystectomy were randomized into two groups (groups A and B) in a double-blinded fashion. Both groups were pre-medicated with an injection glycopyrrolate. Group A received 100 mL normal saline (NS) over 10 minutes while group B received dexmedetomidine 0.5 mcg/kg diluted in 100 mL NS over 10 minutes before induction of general anesthesia. Heart rate, systolic, diastolic, and mean arterial pressures were noted. RESULTS: Following pneumoperitoneum, there was no statistically significant difference in the hemodynamic parameters between the two groups (P > 0.05). CONCLUSION: Administration of dexmedetomidine at a dose of 0.5 mcg/kg before induction did not blunt the hemodynamic responses to pneumoperitoneum during laparoscopic cholecystectomy.


Subject(s)
Cholecystectomy, Laparoscopic , Dexmedetomidine , Pneumoperitoneum , Humans , Adolescent , Young Adult , Adult , Middle Aged , Dexmedetomidine/pharmacology , Pneumoperitoneum/drug therapy , Hemodynamics , Adrenergic alpha-2 Receptor Agonists/pharmacology
5.
Eur J Obstet Gynecol Reprod Biol ; 280: 73-77, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36434823

ABSTRACT

OBJECTIVE: Minimally invasive hysterectomy is a commonly performed gynecologic procedure with associated postoperative pain managed with opioid medications. Uncontrolled postoperative pain leads to increased opioid use/abuse, longer hospital stays, increase in healthcare visits, and may negatively affect patient satisfaction. Current data suggests that reduced pneumoperitoneum insufflation pressure during laparoscopic surgery may impact postoperative pain. Given the current opioid epidemic, surgeons are proactively finding ways to reduce postoperative pain. It is unclear how reduced pneumoperitoneum pressure impacts the surgeon. We investigated the impact of reduced pneumoperitoneum insufflation pressure on surgeon satisfaction. STUDY DESIGN: This was a pilot, double-blinded, randomized controlled trial from March 2020 to July 2021 comparing pneumoperitoneum pressure of 15 mmHg to reduced pressures of 12 mmHg and 10 mmHg during laparoscopic hysterectomy. RESULTS: A total of 40 patients were randomized (13 - 15 mmHg, 13 - 12 mmHg, and 14 - 10 mmHg). The primary outcome was surgeon satisfaction. Secondary outcomes included patient satisfaction, operative time, blood loss, postoperative pain, opioid usage, and discharge timing. There were no differences in baseline demographics or perioperative characteristics. Surgeon satisfaction was negatively impacted with lower pneumoperitoneum pressures greatest with 10 mmHg, including overall satisfaction (p =.01), overall effect of the pneumoperitoneum (p =.04), and quality of visualization (p =.01). There was an apparent although not statistically significant difference in operative time (p =.06) and blood loss (p =.054). There was no difference in patient satisfaction, postoperative pain scores, opioid usage, or time to discharge. CONCLUSION(S): Reduced pneumoperitoneum insufflation pressure during laparoscopic hysterectomy negatively impacted surgeon satisfaction with a trend towards longer operative times and greater blood loss, and did not positively impact patient satisfaction, postoperative pain, opioid demand, or discharge timing.


Subject(s)
Insufflation , Laparoscopy , Pneumoperitoneum , Humans , Female , Pneumoperitoneum/etiology , Pneumoperitoneum/drug therapy , Analgesics, Opioid/therapeutic use , Insufflation/methods , Laparoscopy/adverse effects , Pain, Postoperative/etiology , Pain, Postoperative/prevention & control , Pain, Postoperative/drug therapy , Hysterectomy/adverse effects , Hysterectomy/methods , Pneumoperitoneum, Artificial/adverse effects , Pneumoperitoneum, Artificial/methods
6.
Obes Res Clin Pract ; 16(2): 170-173, 2022.
Article in English | MEDLINE | ID: mdl-35396195

ABSTRACT

INTRODUCTION: Sleeve gastrectomy has currently become the most commonly performed bariatric. procedure worldwide according to the last IFSO survey, overtaking gastric bypass with. a share of more than 50% of all primary bariatric-metabolic surgery. Gastric leak, intraluminal bleeding, bleeding from the staple-line and strictures are the most common complications. Portomesenteric vein thrombosis (PMVT)after sleeve gastrectomy is. another complication that has been increasingly reported in case-series in recent.years, although it remains uncommon. In this case report is described an extended portomesenteric vein thrombosis after. sleeve gastrectomy interesting splenic vein too with a favorable course and an. uneventful follow-up. We try to search in this case for pathogenetic factors involved in. this complication. CASE REPORT: A 42-year old man, with a body mass index (BMI) of 45 kg/m2, with a medical history of Obstructive Sleep Apnea Sindrome (OSAS) underwent laparoscopic sleeve gastrectomy. Early postoperative course was uneventful. Six days after discharge he complained abdominal pain and was admitted at the Emergency Department. A CT scan with intravenous contrast showed an occlusion of the portal vein, of the intrahepatic major branches and an extension to the superior mesenteric vein and the splenic vein. The patient received heparin and oral anticoagulation together with intravenous hydration and proton pump inhibitors. Considering the favourable course the patient was discharged after six days with long-term oral anticoagulation therapy. Anticoagulation with acenocumarol was continued for six months after a CT scan showed resolution of the PMVT without cavernoma. He had no recurrence of symptoms. DISCUSSION: Porto-mesenteric thrombosis after sleeve gastrectomy is a rare complication but it has been increasingly reported over the last 10 years along with the extensive use of sleeve gastrectomy. Because PMVT is closely associated with sleeve gastrectomy in comparison with other bariatric procedures, we need to investigate what pathogenetic factors are involved in sleeve gastrectomy. Thrombophylic state, prolonged duration of surgery, high levels of pneumoperitoneum, thermal injury of the gastroepiploic vessels during greater curvature dissection, high intragastric pressure, inadequate antithrombotic prophylaxis and delayed mobilization of the patient after surgery have been reported as pathogenetic factors of portmesenteric vein thrombosis. Most of the cases presented in the literature such as our clinical case resolve with medical therapy, although portal vein thrombus extends into the superior mesenteric vein and the splenic vein. CONCLUSION: Portomesenteric venous thrombosis is a rare but serious complication of bariatric surgery, especially associated with sleeve gastrectomy. Diagnosis is based on CT examination with intravenous contrast, and initial therapy is anticoagulation. Etiologic factors reported in the literature include a long duration of surgery, a high degree of pneumoperitoneum, high intragastric pressure after sleeve gastrectomy and thermal injury to the short gastric vessels and gastroepiploic arcade. Limited operative time, controlled values of pneumoperitoneum, careful dissection with energy device of gastric greater curvature, appropriate prophylaxis with low molecular weight heparin may be useful tools to prevent and limit this complication. Nonetheless we have to search which factors may condition the evolution of an extended PMVT as that described in this case towards resolution or to a further worsening clinical state. Early diagnosis? Correct treatment? Undiscovered patientrelated factors?


Subject(s)
Laparoscopy , Obesity, Morbid , Pneumoperitoneum , Venous Thrombosis , Adult , Anticoagulants/therapeutic use , Gastrectomy/adverse effects , Gastrectomy/methods , Humans , Laparoscopy/adverse effects , Laparoscopy/methods , Male , Obesity, Morbid/surgery , Pneumoperitoneum/complications , Pneumoperitoneum/drug therapy , Pneumoperitoneum/surgery , Postoperative Complications/etiology , Postoperative Complications/surgery , Retrospective Studies , Venous Thrombosis/etiology , Virulence Factors/therapeutic use
7.
J Cancer Res Ther ; 17(5): 1253-1260, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34850775

ABSTRACT

OBJECTIVE: The effect of CO2 pneumoperitoneum (CDP) on the oncology outcomes of patients undergoing laparoscopic radical hysterectomy for cervical cancer remains unclear. In this study, we investigated the effects of CDP on the proliferation of cervical cancer cells and examined the molecular mechanism. MATERIALS AND METHODS: We established an in vitro CDP model to study the effects of CDP on the proliferation of cervical cancer cells by Cell Counting Kit-8 (CCK-8) assay, xenografted tumor assay. Tandem mass tag-based quantitative proteomics were used to study the proteomic changes in HeLa cells after CDP treatment. Western blot assay was used to detect the expressions of PI3K/Akt signaling pathway proteins. RESULTS: CDP increased cell proliferation after a short period of inhibition in vitro and promoted tumorigenesis in vivo. Proteomic analysis showed that the expression levels of 177 and 309 proteins were changed significantly 24 and 48 h after CDP treatment, respectively. The acidification caused by CO2 inhibited the proliferation of cervical cancer cells by inhibiting the phosphorylation of PI3K and Akt. CONCLUSIONS: CDP promoted the proliferation of human cervical cancer cells after a short time of inhibition. The mechanism of which is related to the inhibition of phosphorylation of the PI3K/Akt signaling pathway.


Subject(s)
Biomarkers, Tumor/metabolism , Carbon Dioxide/pharmacology , Gene Expression Regulation, Neoplastic/drug effects , Pneumoperitoneum/metabolism , Proteome/analysis , Proteome/metabolism , Uterine Cervical Neoplasms/metabolism , Animals , Apoptosis , Cell Proliferation , Female , Humans , Laparoscopy , Mice , Mice, Inbred BALB C , Mice, Nude , Pneumoperitoneum/drug therapy , Pneumoperitoneum/pathology , Proteomics/methods , Tumor Cells, Cultured , Uterine Cervical Neoplasms/drug therapy , Uterine Cervical Neoplasms/pathology , Xenograft Model Antitumor Assays
8.
Minerva Chir ; 62(6): 497-502, 2007 Dec.
Article in Italian | MEDLINE | ID: mdl-18091659

ABSTRACT

Spontaneous pneumoperitoneum is the radiographic manifestation of free air in the peritoneal cavity without visceral perforations and peritoneal signs, and it occurs in about 10% of the cases of pneumoperitoneum. The etiology can be postoperative, thoracic, abdominal, gynecologic, idiopathic; it generally introduces a benign evolution and does not require surgical treatment but just a conservative approach. The authors describe here a case of spontaneous pneumoperitoneum secondary to thoracic trauma. This case is interesting for the occurrence of pneumoperitoneum without clinical peritoneal signs such as fever and leucocytosis, after closed thoracic trauma in absence of pneumothoracic and pneumomediastinum. Correct clinical approach has allowed a conservative treatment avoiding an useless laparotomy.


Subject(s)
Pneumoperitoneum/etiology , Thoracic Injuries/complications , Wounds, Nonpenetrating/complications , Accidental Falls , Aged , Anti-Bacterial Agents/therapeutic use , Diuretics/therapeutic use , Follow-Up Studies , Humans , Infant, Newborn , Male , Oxygen Inhalation Therapy , Pneumoperitoneum/diagnosis , Pneumoperitoneum/diagnostic imaging , Pneumoperitoneum/drug therapy , Pneumoperitoneum/therapy , Radiography, Thoracic , Thoracic Injuries/diagnostic imaging , Thoracic Injuries/etiology , Time Factors , Treatment Outcome , Wounds, Nonpenetrating/diagnostic imaging , Wounds, Nonpenetrating/etiology
9.
Shock ; 25(1): 23-9, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16369182

ABSTRACT

Insufflation of ozonized oxygen into the peritoneum (O3/O2-pneumoperitoneum [O3/O2-PP]) of rats reduced the lethality of peritonitis. We evaluated the prophylactic effect of O3/O2-PP combined with tazobactam/piperacillin (TZP) in polymicrobial lethal peritonitis. Wistar rats were conditioned by daily repeated insufflation of ozone for 5 days, and hematologic parameters were determined. Sepsis was induced by i.p. injection of cecal material derived from donor rats. Simultaneously, TZP was applied at a single dosage of 65 mg/kg or at two dosage schedules of 65 mg/kg each at an interval of 1 h. The conditioning effect of O3/O2-PP on the number of blood cells was measured before inoculation of bacteria. The mRNA levels of proinflammatory cytokine IL-lbeta and TNF-alpha were determined at 4 h post infection in spleen and liver by semiquantitative in situ hybridization analysis. Preconditioning of rats by O3/O2-PP enhanced the number of blood leukocytes and granulocytes and increased the survival rate of septic rats up to 33%. The combination of O3/O2-PP and TZP further enhanced the survival rate up to 93%. This effect was accompanied by a reduced amount of IL-1beta and TNF-alpha mRNA in spleen and liver. In contrast, in non-infected animals the combination of O3/O2-PP and TZP enhanced IL-1beta and TNF-alpha mRNA in the spleen and IL-1beta mRNA in liver when compared with TZP- and sham-treated controls. The preconditioning effect of O3/O2-PP seems to support the biological effectiveness of TZP by altering the immune status before and during the onset of sepsis. The combined therapy could be a simple, preoperative intervention for abdominal surgery to reduce postoperative morbidity and mortality.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Enzyme Inhibitors/administration & dosage , Penicillanic Acid/analogs & derivatives , Peritonitis/drug therapy , Piperacillin/administration & dosage , Pneumoperitoneum/drug therapy , Animals , Drug Therapy, Combination , Interleukin-1/biosynthesis , Male , Ozone/administration & dosage , Ozone/toxicity , Penicillanic Acid/administration & dosage , Peritonitis/metabolism , Peritonitis/pathology , Pneumoperitoneum/chemically induced , Pneumoperitoneum/metabolism , Pneumoperitoneum/pathology , Rats , Rats, Wistar , Tazobactam , Tumor Necrosis Factor-alpha/biosynthesis
10.
Yonsei Med J ; 57(1): 238-46, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26632407

ABSTRACT

PURPOSE: Oxidative stress during CO2 pneumoperitoneum is reported to be associated with decreased bioactivity of nitric oxide (NO). However, the changes in endothelial nitric oxide synthase (eNOS), inducible nitric oxide synthase (iNOS), and arginase during CO2 pneumoperitoneum have not been elucidated. MATERIALS AND METHODS: Thirty male Sprague-Dawley rats were randomized into three groups. After anesthesia induction, the abdominal cavities of the rats of groups intra-abdominal pressure (IAP)-10 and IAP-20 were insufflated with CO2 at pressures of 10 mm Hg and 20 mm Hg, respectively, for 2 hours. The rats of group IAP-0 were not insufflated. After deflation, plasma NO was measured, while protein expression levels and activity of eNOS, iNOS, arginase (Arg) I, and Arg II were analyzed with aorta and lung tissue samples. RESULTS: Plasma nitrite concentration and eNOS expression were significantly suppressed in groups IAP-10 and IAP-20 compared to IAP-0. While expression of iNOS and Arg I were comparable between the three groups, Arg II expression was significantly greater in group IAP-20 than in group IAP-0. Activity of eNOS was significantly lower in groups IAP-10 and IAP-20 than in group IAP-0, while iNOS activity was significantly greater in group IAP-20 than in groups IAP-0 and IAP-10. Arginase activity was significantly greater in group IAP-20 than in groups IAP-0 and IAP-10. CONCLUSION: The activity of eNOS decreases during CO2 pneumoperitoneum, while iNOS activity is significantly increased, a change that contributes to increased oxidative stress and inflammation. Moreover, arginase expression and activity is increased during CO2 pneumoperitoneum, which seems to act inversely to the NO system.


Subject(s)
Aorta/physiology , Arginase/antagonists & inhibitors , Inflammation/prevention & control , Nitric Oxide Synthase Type III/metabolism , Nitric Oxide Synthase Type II/metabolism , Oxidative Stress/drug effects , Pneumoperitoneum/complications , Animals , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacology , Inflammation/etiology , Injections, Subcutaneous , Lung Injury/etiology , Lung Injury/prevention & control , Male , Nitric Oxide/metabolism , Pneumoperitoneum/drug therapy , Rats , Rats, Sprague-Dawley
11.
Arch Surg ; 124(7): 830-2, 1989 Jul.
Article in English | MEDLINE | ID: mdl-2742484

ABSTRACT

This report concerns 35 adult patients in whom perforation of a duodenal or prepyloric ulcer was treated nonoperatively between July 1979 and April 1988 at the Los Angeles County--University of Southern California Medical Center, Los Angeles. Each patient had pneumoperitoneum with clinical evidence of peritonitis, and a gastroduodenogram documented a sealed perforation. The ulcer was believed to be acute in 27 patients and chronic in 8. These 35 cases represent 12% of 294 cases of duodenal and prepyloric peptic ulcers with perforation treated during the same period. An intra-abdominal abscess developed in 1 of the 35 patients. Reperforation did not occur. The mortality rate for the 259 cases treated operatively during this period was 6.2%; the mortality rate of the 35 cases treated nonoperatively was 3%. Duodenal ulcer can be safely treated nonoperatively when a gastroduodenogram documents self-sealing.


Subject(s)
Duodenal Ulcer/therapy , Peptic Ulcer Perforation/therapy , Adult , Aged , Aged, 80 and over , Duodenal Ulcer/complications , Duodenal Ulcer/mortality , Female , Humans , Length of Stay , Male , Middle Aged , Peptic Ulcer Perforation/complications , Peptic Ulcer Perforation/mortality , Peritonitis/drug therapy , Peritonitis/etiology , Pneumoperitoneum/drug therapy , Pneumoperitoneum/etiology
12.
Cir Pediatr ; 9(4): 171-2, 1996 Oct.
Article in Spanish | MEDLINE | ID: mdl-9131987

ABSTRACT

We report one case of spontaneum pneumoperitoneum without peritonitis in a male newborn was admitted in Infantil Robert Reid Cabral Hospital. Many radiological studies were carried out. Its treatment was conservative. The child had excellent evolution. We recommend this treatment for all the patient who has the same features.


Subject(s)
Peritonitis/diagnosis , Pneumoperitoneum/drug therapy , Anti-Bacterial Agents/therapeutic use , Combined Modality Therapy , Humans , Infant, Newborn , Male , Parenteral Nutrition , Pneumoperitoneum/physiopathology
13.
Pol Merkur Lekarski ; 12(70): 304-5, 2002 Apr.
Article in Polish | MEDLINE | ID: mdl-12089894

ABSTRACT

Pneumoperitoneum is a rare complication of peritoneal dialysis, which in most cases occurs soon after the implantation of the peritoneal catheter and does not need any specific treatment. In contrast, pneumoperitoneum due to visceral perforation represents a serious clinical problem and usually needs an urgent surgical intervention. We present a case of a 10-year old girl treated by peritoneal dialysis for 7 months who was admitted to hospital with symptoms of peritonitis and pneumoperitoneum. On admission her condition was severe and visceral perforation was strongly suspected. As her parents did not give consent to surgical treatment, only conservative management was introduced. Peritoneal dialysis was continued and the girl responded well to antibacterial therapy. The final outcome was favourable.


Subject(s)
Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritonitis/etiology , Pneumoperitoneum/etiology , Anti-Infective Agents/therapeutic use , Child , Female , Humans , Peritonitis/drug therapy , Peritonitis/microbiology , Pneumoperitoneum/drug therapy , Treatment Outcome
14.
Heart Lung ; 39(5): 444-7, 2010.
Article in English | MEDLINE | ID: mdl-20561891

ABSTRACT

OBJECTIVE: We describe the clinical features of a 17-year-old girl with severe asthma exacerbations. On admission to the intensive care unit, she manifested expiratory dyspnea, cyanosis, and an unproductive cough. Her chest x-rays showed extensive pneumomediastinum (PM), mild subcutaneous emphysema at the right anterior triangle of the neck, and right upper-lobe atelectasis. Her PM resulted from the "Macklin effect," which involves a three-step process: overly distended alveolar rupture, air dissection along the bronchovascular sheaths, and air spreading into the mediastinum. METHODS: Treatment consisted of oxygen therapy, parenteral corticosteroids, and nebulized bronchodilators. RESULTS: She made a good recovery, and was discharged from the intensive care unit after 2 days. CONCLUSION: This case illustrates that conservative management strategies in this severe and unusual complication of asthma exacerbation can result in rapid and complete recovery. Nonetheless, every asthma exacerbation should be considered potentially life-threatening, and must be treated promptly and adequately.


Subject(s)
Asthma/complications , Pneumoperitoneum/etiology , Pulmonary Atelectasis/etiology , Subcutaneous Emphysema/etiology , Adolescent , Adrenal Cortex Hormones/therapeutic use , Asthma/drug therapy , Asthma/therapy , Blood Gas Analysis , Bronchodilator Agents/therapeutic use , Female , Humans , Oxygen Inhalation Therapy , Pneumoperitoneum/drug therapy , Pneumoperitoneum/therapy , Pulmonary Atelectasis/drug therapy , Pulmonary Atelectasis/therapy , Risk Factors , Subcutaneous Emphysema/drug therapy , Subcutaneous Emphysema/therapy , Time Factors
15.
Acta Cir Bras ; 24(2): 124-7, 2009.
Article in English | MEDLINE | ID: mdl-19377781

ABSTRACT

PURPOSE: To assess the bactericidal action of ozone pneumoperitonium, and to compare the results with CO2. METHODS: It was used 36 Wistar rats. The animals, under anesthesia, were inoculated with 2ml of E. coli ATCC at a concentration of 10(10)UFC, and 1ml of BaSO4, into the peritoneal cavity. They were divided into three groups: Group 1, CO2 pneumoperitoneum was performed for 15 minutes; Group 2, ozone pneumoperitoneum was performed for 5 minutes at a concentration of 42microg/ml, and Group 3, ozone pneumoperitoneum was performed for 5 minutes at a concentration of 62microg/ml. Six animals from each group were sacrificed after the experiment, and the remaining 6 observed for 24 hours. Material was collected from the cavity of all animals for microbiological study. RESULTS: Ozone presented a greater bactericidal effect than CO2 in those animals sacrificed immediately after pneumoperitoneum. In the animals studied 24 hours after pneumoperitoneum evidenced no difference in bactericidal effect between the two gases. Moreover, no difference in mortality was observed. CONCLUSION: Ozone has a more potent bactericidal effect than carbon dioxide gas, although this did not influence survival of the animals.


Subject(s)
Anti-Bacterial Agents/pharmacology , Escherichia coli/drug effects , Ozone/pharmacology , Peritonitis/microbiology , Pneumoperitoneum/microbiology , Animals , Carbon Dioxide/pharmacology , Peritonitis/drug therapy , Pneumoperitoneum/drug therapy , Rats , Rats, Wistar , Statistics, Nonparametric
16.
Ryumachi ; 38(6): 825-30, 1998 Dec.
Article in Japanese | MEDLINE | ID: mdl-10047721

ABSTRACT

We report a case of systemic sclerosis (SSc) complicated with benign pneumoperitoneum without apparent pneumatosis cystoides intestinalis (PCI). A 43-year-old woman was admitted to our hospital because of prominent abdominal distension in April 1997. Raynaud's phenomenon has been detected since 1991. She was suffering from recurrent diarrhea, constipation, and subileus. The diagnosis of SSc was made in 1996 based on the sclerosis in her face, forearms, and chest, and hypomotility of the esophagus. On admission, she presented no signs of peritoneal irritation. The laboratory data revealed that white blood cell count was 7,400/mm3 and C-reactive protein was 0.1 mg/dl. Chest and abdominal roentgenograms showed massive free air under the diaphragm, dilatation of small and large intestine, and air-fluid level. PCI was not apparent. Pneumoperitoneum was improved after four weeks with intravenous hyperalimentation. But she presented recurrent severe diarrhea and high fever whenever she tried to take food orally. Klebsiella pneumoniae was proved in her jejunal juice by bacteriologic examination. Intravenous prostaglandin F2 alpha and oral fosfomycin calcium intake made her condition better. Benign pneumoperitoneum without PCI is rarely reported in the patients with SSc. In her condition, weakness of intestinal wall, hypomotility of intestine, unusual bacterial overgrowth, and elevated intraluminal pressure made intraluminal gas go through the wall of the fragile intestine of SSc. As operation of intestine of SSc usually cause miserable outcome, pneumoperitoneum accompanied with SSc even if PCI is apparent or not must be treated with conventional manner while there is no signs of peritoneal irritation.


Subject(s)
Pneumoperitoneum/etiology , Scleroderma, Systemic/complications , Adult , Anti-Bacterial Agents/therapeutic use , Dinoprost/therapeutic use , Duodenum/microbiology , Female , Fosfomycin/therapeutic use , Humans , Klebsiella pneumoniae/isolation & purification , Pneumatosis Cystoides Intestinalis , Pneumoperitoneum/drug therapy
17.
Dig Dis Sci ; 37(6): 949-54, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1587203

ABSTRACT

A 66-year-old man with chronic idiopathic intestinal pseudoobstruction was admitted for pneumatosis cystoides intestinalis, complicated by pneumoperitoneum. The latter conditions resolved after treatment with metronidazole. There was no favorable effect of the prokinetic agents cisapride and erythromycin. To the authors' knowledge, this is the first reported case of successful treatment of pneumatosis cystoides intestinalis with metronidazole in primary chronic intestinal pseudoobstruction.


Subject(s)
Intestinal Pseudo-Obstruction/complications , Metronidazole/therapeutic use , Pneumatosis Cystoides Intestinalis/complications , Aged , Humans , Male , Pneumatosis Cystoides Intestinalis/diagnostic imaging , Pneumatosis Cystoides Intestinalis/drug therapy , Pneumoperitoneum/complications , Pneumoperitoneum/diagnostic imaging , Pneumoperitoneum/drug therapy , Radiography
18.
Acta cir. bras ; Acta cir. bras;24(2): 124-127, Mar.-Apr. 2009. tab
Article in English | LILACS | ID: lil-511326

ABSTRACT

PURPOSE: To assess the bactericidal action of ozone pneumoperitonium, and to compare the results with CO2. METHODS: It was used 36 Wistar rats. The animals, under anesthesia, were inoculated with 2ml of E. coli ATCC at a concentration of 10(10)UFC, and 1ml of BaSO4, into the peritoneal cavity. They were divided into three groups: Group 1, CO2 pneumoperitoneum was performed for 15 minutes; Group 2, ozone pneumoperitoneum was performed for 5 minutes at a concentration of 42µg/ml, and Group 3, ozone pneumoperitoneum was performed for 5 minutes at a concentration of 62µg/ml. Six animals from each group were sacrificed after the experiment, and the remaining 6 observed for 24 hours. Material was collected from the cavity of all animals for microbiological study. RESULTS: Ozone presented a greater bactericidal effect than CO2 in those animals sacrificed immediately after pneumoperitoneum. In the animals studied 24 hours after pneumoperitoneum evidenced no difference in bactericidal effect between the two gases. Moreover, no difference in mortality was observed. CONCLUSION: Ozone has a more potent bactericidal effect than carbon dioxide gas, although this did not influence survival of the animals.


OBJETIVO: Avaliar a ação bactericida do pneumoperitônio de ozônio comparando-o à ação do CO2. MÉTODOS: Foram utilizados 36 ratos Wistar. Após anestesia e inoculação de 2ml de E. coli ATCC na concentração de 10(10) UFC e 1ml de BaSO4 na cavidade peritoneal, os animais foram divididos em três grupos: Grupo 1, realização de pneumoperitônio de CO2 por 15 minutos; Grupo 2, realização de pneumoperitônio de ozônio durante 5 minutos na concentração de 42µg/ml, e Grupo 3, realização de pneumoperitônio de ozônio durante 5 minutos na concentração de 62µg/ml. Seis animais de cada grupo foram sacrificados após experimento e os outros seis foram observados por 24 horas. Em todos os animais colheu-se material da cavidade para estudo microbiológico. RESULTADOS: O ozônio teve maior efeito bactericida em comparação ao CO2 nos animais sacrificados logo após pneumoperitônio. Nos animais estudados após 24 horas não houve diferença do efeito bactericida entre os gases. Também não se observou alteração da mortalidade. CONCLUSÃO: O ozônio tem efeito bactericida mais potente que o gás carbônico, embora não tenha influenciado a sobrevida dos animais.


Subject(s)
Animals , Rats , Anti-Bacterial Agents/pharmacology , Escherichia coli/drug effects , Ozone/pharmacology , Peritonitis/microbiology , Pneumoperitoneum/microbiology , Carbon Dioxide/pharmacology , Peritonitis/drug therapy , Pneumoperitoneum/drug therapy , Rats, Wistar , Statistics, Nonparametric
19.
Rev. esp. anestesiol. reanim ; 58(4): 211-217, abr. 2011. tab
Article in Spanish | IBECS (Spain) | ID: ibc-128938

ABSTRACT

Objetivos: La cirugía bariátrica laparoscópica supone un reto para el anestesiólogo, ya que el obeso mórbido es un paciente de alto riesgo y la laparoscopia puede dificultar el tratamiento ventilatorio y hemodinámico del paciente. El objetivo de este estudio es analizar el tratamiento perioperatorio anestésico de pacientes obesos mórbidos sometidos a cirugía bariátrica laparoscópica. Material y métodos: Estudio prospectivo de 300 pacientes consecutivos diagnosticados de obesidad mórbida, programados para cirugía bariátrica por laparoscopia. Los pacientes se posicionaron con almohadillado en cuña bajo cabeza y hombros. Se llevó a cabo una inducción anestésica de secuencia rápida. Para la intubación se utilizó un laringoscopio de mango corto y pala articulada (McCoy), utilizando de rescate la ILMA (intubation laryngeal mask airway) o Fastrach. El mantenimiento anestésico se realizó con propofol y remifentanilo, administrando cloruro mórfico al final de la cirugía. En la unidad de reanimación postanestésica se inició espirometría incentivada. Resultados: El 80% fueron mujeres, con un índice de masa corporal de 46 ± 5 Kg/m2. Se utilizó de primera elección laringoscopia directa para intubar en el 98,6% de los casos. Ningún paciente fue imposible de intubar. Sólo 5 pacientes precisaron cuidados intensivos. Hubo un 17% de complicaciones postoperatorias, destacando las respiratorias, hemorrágicas e infecciosas. No hubo ningún caso de mortalidad. Conclusión: El manejo perianestésico de pacientes con obesidad mórbida operados mediante abordaje laparoscópico es seguro. Para minimizar las complicaciones respiratorias, conviene: preoxigenar adecuadamente, realizar inducción de secuencia rápida y comenzar la espirometría incentivada en el postoperatorio inmediato. El laringoscopio de McCoy garantiza la intubación en la mayoría de los casos(AU)


Objectives: Laparoscopic bariatric surgery is a challenge for anesthesiologists because morbidly obese patients are at high risk and laparoscopy may complicate respiratory and hemodynamic management. The aim of this study was to analyze the perioperative anesthetic management of morbidly obese patients undergoing laparoscopic bariatric surgery. Material and methods: Prospective study of 300 consecutive patients diagnosed with morbid obesity and scheduled for laparoscopic bariatric surgery. Patients were positioned with a wedge cushion under the head and shoulders. A rapid sequence induction of anesthesia was carried out. A short-handled, articulated-blade McCoy laryngoscope was used for intubation; an intubation laryngeal mask airway (Fastrach) was on hand as a rescue device. Propofol and remifentanil were used for maintenance of anesthesia and morphine was administered at the end of surgery. Incentive spirometry was initiated in the postanesthetic recovery unit. Results: Eighty percent of the patients were women with a mean (SD) body mass index (kg/m2) of 46 (5). The first choice of direct laryngoscopic intubation was successful in 98.6% of cases. All patients were successfully intubated. Only 5 patients required intensive care. Postoperative complications (mainly respiratory problems, bleeding, and infections) were observed in 17%. No patient died. Conclusions: Perianesthetic management of morbidly obese patients who undergo laparoscopic surgery is safe. To minimize pulmonary complications, preoxygenation and rapid sequence induction should be performed correctly and incentive spirometry should be initiated in the immediate postoperative period. The McCoy laryngoscope ensures intubation in most cases(AU)


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Anesthesia/methods , Anesthesia/statistics & numerical data , Obesity, Morbid/diagnosis , Obesity, Morbid/drug therapy , Obesity, Morbid/surgery , Bariatric Surgery/methods , Laparoscopy/methods , Preoperative Care/methods , Anesthesia, General/methods , Propofol/therapeutic use , Obesity, Morbid/physiopathology , Anesthesia, General/trends , Anesthesia, General , Pneumoperitoneum/drug therapy , Pneumoperitoneum/surgery , Prospective Studies , Ranitidine/therapeutic use , Midazolam/therapeutic use , Postoperative Complications/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL